1.HSBC Holdings plc
HBCYF (OTC)
With a solid dividend yield of 4.60%, this investment has delivered impressive returns of 53.29% over the past year and a remarkable 261.02% over the last five years. However, recent downgrades from Goldman Sachs and Exane BNP Paribas to Neutral, contrasted with UBS's upgrade to Buy, suggest mixed sentiment among analysts. Investors should weigh the attractive yield and strong historical performance against the current analyst outlook.
Pros:
- High dividend yield
- Strong long-term returns
Cons:
- Market volatility risk
- Potential regulatory challenges
2.GSK plc
GSK (NYSE)
With a solid dividend yield of 3.62% and impressive returns of 37.12% over the past year and 29.93% over the last five years, this investment demonstrates strong performance potential. However, recent analyst downgrades, including Barclays and Jefferies, suggest caution, while the median 12-month price target of $53.00 indicates room for growth within a range of $35.25 to $85.00. Investors should weigh these factors carefully when considering their positions.
Pros:
- Strong dividend yield
- Diverse product portfolio
Cons:
- Recent stock performance volatility
- Regulatory risks
3.Unilever PLC
UNI2.DE (XETRA)
Unilever is currently navigating a transformative phase as it emphasizes its core brands and plans a merger with McCormick, which could strengthen its competitive edge in the market. Despite these strategic moves, the stock is perceived as undervalued, and it holds an analyst rating of S-. Investors should consider these factors when evaluating potential opportunities within Unilever's stock.
Pros:
- Strong brand portfolio
- Focus on core brands
Cons:
- Execution challenges
- Competition in the food sector
4.AstraZeneca plc
ZEG.DE (XETRA)
AstraZeneca has received a favorable B+ rating from analysts, indicating strong growth potential. While investors may need to accept a higher-than-average market multiple, the company is positioned well for quality long-term returns, making it an attractive investment option for those focused on sustained growth.
Pros:
- Strong pipeline of drugs
- Good long-term growth potential
Cons:
- High valuation compared to peers
- Market competition
5.Shell plc
RDSA.L (LSE)
The stock currently offers a 0% dividend yield and has not generated any returns over the past year or five years. Despite this stagnation, analysts remain optimistic, with ratings of Overweight from Barclays and Wells Fargo, along with a Buy from Societe Generale, suggesting potential for future growth. Investors should consider these ratings in light of the current performance metrics when making decisions.
Pros:
- Strong market presence
- Diverse energy portfolio
Cons:
- No current dividend yield
- Exposure to oil price fluctuations
Final Words
As you consider the best blue chip stocks this August 2026 in the UK, remember to evaluate your investment options carefully. Take the time to compare these stocks and conduct thorough research to ensure you make informed decisions that align with your financial goals.
Frequently Asked Questions
HSBC Holdings plc is considered a top blue chip stock due to its solid financial performance, including a 1-year return of 53.29% and a 5-year return of 261.02%. Additionally, it offers a competitive dividend yield of 4.60%, providing investors with regular income.
HSBC Holdings pays dividends on a quarterly basis. The next dividend is set at $0.1000, with the previous dividend date occurring on June 26, 2026.
As of August 2026, HSBC Holdings plc has a market capitalization of $340.58 billion. This substantial market cap reflects its strong position in the financial services sector.
While blue chip stocks are typically considered safer investments, they are not without risks. Economic downturns, changes in interest rates, and sector-specific challenges can impact their performance.
HSBC's performance can be compared to other blue chip stocks by looking at its returns and dividends. For example, its 3-year return of 144.09% and consistent dividend payments position it favorably among its peers in the financial services sector.
